On July 16, 2025, the UK Government published the Life Sciences Sector Plan, which outlines targeted actions to support world-class research and development, attract investment, and accelerate health innovation and NHS reform. The key actions to ensure faster access to clinically and cost-effective technologies include implementing the Rules-Based Pathway for MedTech, “Innovator Passport”, national standard guidance on value-based procurement for MedTech, and “HealthStore” (coverage of approved health apps for patients).

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Davies et al. systematically reviewed implementation approaches to improve environmental sustainability in operating theatres.

On July 15, 2025, the Ministry of Labor, Health, Solidarity, and Families published the instruction on the application for coverage with evidence development programs for 2025-2026. The instruction details the specific fields of research, the application procedures, and the deadlines for different types of programs (PHRC, PRME, PREPS, PHRIP, and PRT).

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Yan et al. systematically reviewed statistical approaches used to analyze EQ-5D outcomes in randomized clinical trials worldwide.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of July 28th, we plan to work on 16 projects. Review the complete list of planned activities in this post.

On July 15, 2025, the Austrian Institute for HTA (AIHTA) published four new HTAs (decision support documents) and two updates to previous decision support documents that provide recommendations regarding possible inclusion of new procedures in the reimbursement catalog of individual medical services (MEL). The assessments concerned cardiovascular, gastrointestinal, interventional radiology, men's health, urology, and orthopedics fields.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Williams et al. compared the authorization and reimbursement processes for two novel cardiovascular devices (Watchman and Impella) in the US, Canada, the UK, and the Netherlands.

On July 10, 2025, a decision of the National Union of Health Insurance Funds regarding the update of the CCAM Classification of Medical Procedures was published. The update includes the provisional registration of one procedure code for transrectal HIFU destruction of prostate lesions and changes to indications and billing notes for several existing codes. The update takes effect on September 1, 2025.

On July 10, 2025, the National Association of Statutory Health Insurance Physicians (KBV) announced that the extended Evaluation Committee has adopted the framework specifications for calculating Hybrid DRGs for 2026.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Bobini et al. conducted an international survey of health technology assessment (HTA) organizations across 20 countries to explore global progress in integrating environmental sustainability into HTA.

MTRC has released a White Paper titled "Clinical evidence requirements for the “Orderly Introduction of Medical Technologies” process in Sweden". This report provides an opportunity to learn about the evidence requirements of Sweden's Dental and Pharmaceutical Benefits Agency (TLV) and the Medical Technology Product (MTP) Council in relation to the national process of Orderly Introduction of medical technologies. White Paper outlines the key points and recommendations for the MedTech industry informed by three HTA reports with positive recommendations.

On July 9, 2025, the NHS Cancer Programme granted £14.4 million to seven projects through the third Innovation Open Call. The projects aimed to fast-track the implementation of proven, late-stage innovations for the early detection and diagnosis of cancer.